Awareness, knowledge and self-reported test rates regarding Hepatitis B in Turkish-Dutch: a survey

van der Veen, Ytje J. J.; Voeten, Hélène A. C. M.; de Zwart, Onno; Richardus, Jan Hendrik
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p512
Academic Journal
Background: Hepatitis B virus infection is an important health problem in the Turkish community in the Netherlands. To prevent transmission and progression of the disease in this community, increased screening is necessary. This study aimed to determine 1) the levels of awareness and knowledge regarding hepatitis B, comparing these in tested and non-tested Turkish-Dutch in Rotterdam; 2) the self-reported hepatitis B test status in this population, and how this is related to demographic characteristics, knowledge and awareness. Methods: We conducted a postal survey amongst first and second generation migrants, aged 16 - 40 years. Results: The response rate was 30.2% (n = 355 respondents). Levels of awareness and knowledge regarding hepatitis B were low, as the majority of respondents (73%) never thought about the disease and 58% of the respondents scored 5 or less out of ten knowledge items. Weighted analysis of self-reports showed a test rate of 15%, and a vaccination rate of 3%. Regression analysis showed that having been tested for hepatitis B was related to being married and higher levels of awareness and knowledge. Conclusions: This study shows low levels of hepatitis B awareness and knowledge in the Turkish community in Rotterdam. Self-reported test rates are lower in people who are not currently married, and in those who have low levels of awareness and knowledge. Especially, knowledge about the consequences of hepatitis B, such as liver cancer, was lacking. Therefore, a health promotion intervention should foremost raise awareness, and increase knowledge on the seriousness of this disease.


Related Articles

  • France refuses to grant kids immunity. Day, Michael // New Scientist;10/17/98, Vol. 160 Issue 2156, p17 

    Reports that the French health ministry is halting its program of immunizing adolescents against hepatitis B. Concerns that the vaccine could cause multiple sclerosis (MS); Criticism by the World Health Organization (WHO) over this move; Possibility that the program would start again; Why Great...

  • Uptake and Behavioural and Attitudinal Determinants of Immunization in an Expanded Routine Infant Hepatitis B Vaccination Program in British Columbia. Bigham, M.; McIntyre, C.; Remple, V. P.; White, R.; Pielak, K.; Wu, W. // Canadian Journal of Public Health;Mar/Apr2006, Vol. 97 Issue 2, p90 

    Introduction: British Columbia (BC) implemented a universal infant hepatitis B (HB) immunization program in 2001. The study objective was to evaluate HB immunization coverage among the first six-month cohort of eligible infants in the province outside of the Vancouver-Richmond health region and...

  • Outcome of Immunoprophylaxis in HBsAg--Positive Neonates. SADOVSKY, RICHARD // American Family Physician;2/1/1999, Vol. 59 Issue 3, p662 

    Presents an abstract of the study `Hepatitis B surface antigenemia at birth: A long-term follow-up study,' by J. R. Tang, et al., from `The Journal of Pediatrics' dated September 1998.

  • A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection. Zoulim, F.; Zoulim, Fabien // Drug Safety;May2002, Vol. 25 Issue 7, p497 

    Chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide. Until recently, interferon (IFN)-α was the only approved drug for the treatment of chronic HBV infection. The recent registration of lamivudine, a dideoxycytidine analogue that inhibits both the HIV and...

  • Viral Hepatitis and Injection Drug Use in Appalachian Kentucky: A Survey of Rural Health Department Clients. Christian, W. Jay; Hopenhayn, Claudia; Christian, Amy; McIntosh, Deana; Koch, Alvaro // Public Health Reports;Jan/Feb2010, Vol. 125 Issue 1, p121 

    Objectives. We identified correlates of exposure to hepatitis B and C viruses among health department clients in Appalachian Kentucky, a rural region noted for high poverty and low education. Additionally, we investigated risk factors for transmission, and the frequency of use of preventive...

  • Economic and social factors fighting against hepatitis B and C contagion. ANDRONIE (DIJMĂRESCU), Irina // Revista Romana de Economie;2015, Vol. 40 Issue 1, p184 

    Socioeconomic factors may influence the epidemiology of viral hepatitis. We present the results of an ongoing prospective study which included a number of 56 patients. Sixty-two percent of them came from urban areas and 50% came from medium income families. Ninety percent of the children were in...

  • Inmunogenicidad de una vacuna recombinante anti-HBs en trabajadores de la salud, del Instituto de Medicina Legal de Colombia. Siachoque, Heber; Ibáñez, Milcíades // Colombia Medica;oct-dec2007, Vol. 38 Issue 4, p375 

    Objective: To evaluate the immunogenicity of Hepavax-Gene recombinant hepatitis B vaccine in INML workers since the last administered doses. Methods: Cross-sectional study on 603 health workers with at least three administered recombinant vaccine doses. Antibody levels (anti-HBs) were measured...

  • Hepatitis B Control in China: Knowledge and Practices among Village Doctors. Clayton, Serena; Honglian Yang; Jihui Guan; Zhongsu Lin; Rui Wang // American Journal of Public Health;Dec1993, Vol. 83 Issue 12, p1685 

    Objectives. To guide development of a hepatitis B control program in China, we investigated village doctors' sterilization practices, injection use, vaccination levels, and knowledge and counseling skills. Methods. The head doctor from each village health station in a rural county (n = 260)...

  • Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Guilin Yang; Ailian Liu; Qing Xie; Taylor B. Guo; Bing Wan; Boping Zhou; Jingwu Z. Zhang // International Immunology;Feb2007, Vol. 19 Issue 2, p133 

    Chronic activity of hepatitis B is thought to involve aberrant immune tolerance of unknown mechanism. In this study, we examined the role of CD4+CD25+Foxp3+ regulatory T cells in disease activity and viral clearance in hepatitis B. Patients with chronic active hepatitis B (CAH) and asymptomatic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics